Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events-Reference-Cited by-同舟云学术

Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events

Published:2019-04-01 Issue:4 Volume:179 Page:533
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Schaefer Jordan K.¹,Li Yun²,Gu Xiaokui³,Souphis Nicole M.⁴,Haymart Brian³,Kline-Rogers Eva³,Almany Steven L.⁵,Kaatz Scott⁶,Kozlowski Jay H.⁷,Krol Gregory D.⁶,Sood Suman L.¹,Froehlich James B.³,Barnes Geoffrey D.³

Affiliation:

1. Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor

2. Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor

3. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor

4. College Student, Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor

5. Department of Internal Medicine, Beaumont Health, Oakland University School of Medicine, Royal Oak, Michigan

6. Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan

7. Department of Cardiovascular Medicine, Huron Valley Sinai Hospital, Commerce Township, Michigan

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

http:///jamainternalmedicine/article-pdf/179/4/533/17452245/jamainternal_schaefer_2019_oi_180124.pdf

Reference33 articles.

1. Comparing direct oral anticoagulants and warfarin for atrial fibrillation, venous thromboembolism, and mechanical heart valves.;Marcy;Consult Pharm,2015

2. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force recommendation statement.;Bibbins-Domingo;Ann Intern Med,2016

3. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.;Vandvik;Chest,2012

4. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.;Fihn;Circulation,2012

5. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary.;Gerhard-Herman;Circulation,2017

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of oral anticoagulants for stroke prevention in atrial fibrillation using the UK clinical practice research Datalink Aurum: A reference trial (ARISTOTLE) emulation study;PLOS Medicine;2024-08-29

2. How I treat the co-occurrence of venous and arterial thromboembolism: anticoagulation, antiplatelet therapy, or both?;Blood;2024-06-06

3. Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study;Research and Practice in Thrombosis and Haemostasis;2024-05

4. Feasibility and acceptability of patient- and clinician-level antithrombotic stewardship interventions to reduce gastrointestinal bleeding risk in patients using warfarin (Anticoagulation with Enhanced Gastrointestinal Safety): a factorial randomized controlled pilot trial;Research and Practice in Thrombosis and Haemostasis;2024-05

5. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease;Nature Reviews Cardiology;2024-03-20